Neurochemical mechanisms of alcohol withdrawal
- PMID: 25307573
- PMCID: PMC6943828
- DOI: 10.1016/B978-0-444-62619-6.00009-4
Neurochemical mechanisms of alcohol withdrawal
Abstract
Alcohol dependence encompasses a serious medical and societal problem that constitutes a major public health concern. A serious consequence of dependence is the emergence of symptoms associated with the alcohol withdrawal syndrome when drinking is abruptly terminated or substantially reduced. Clinical features of alcohol withdrawal include signs of central nervous system hyperexcitability, heightened autonomic nervous system activation, and a constellation of symptoms contributing to psychologic discomfort and negative affect. The development of alcohol dependence is a complex and dynamic process that ultimately reflects a maladaptive neurophysiologic state. Perturbations in a wide range of neurochemical systems, including glutamate, γ-aminobutyric acid, monoamines, a host of neuropeptide systems, and various ion channels produced by the chronic presence of alcohol ultimately compromise the functional integrity of the brain. These neuroadaptations not only underlie the emergence and expression of many alcohol withdrawal symptoms, but also contribute to enhanced relapse vulnerability as well as perpetuation of uncontrolled excessive drinking. This chapter highlights the hallmark features of the alcohol withdrawal syndrome, and describes neuroadaptations in a wide array of neurotransmitter and neuromodulator systems (amino acid and monoamine neurotransmitter, neuropeptide systems, and various ion channels) as they relate to the expression of various signs and symptoms of alcohol withdrawal, as well as their relationship to the significant clinical problem of relapse and uncontrolled dangerous drinking.
Keywords: GABA; alcohol dependence; alcohol withdrawal syndrome; glutamate; ion channels; monoamines; neuroadaptations; neurochemical adaptations; neuropeptides.
© 2014 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Neurochemical mechanisms underlying alcohol withdrawal.Alcohol Health Res World. 1998;22(1):13-24. Alcohol Health Res World. 1998. PMID: 15706728 Free PMC article. Review.
-
How Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal.Alcohol Clin Exp Res. 2015 Dec;39(12):2268-82. doi: 10.1111/acer.12893. Epub 2015 Oct 28. Alcohol Clin Exp Res. 2015. PMID: 26510169 Free PMC article. Review.
-
[Neurobiology of alcohol withdrawal inhibitory and excitatory neurotransmitters].Turk Psikiyatri Derg. 2006 Summer;17(2):129-37. Turk Psikiyatri Derg. 2006. PMID: 16755413 Review. Turkish.
-
Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol.Addict Behav. 2004 Sep;29(7):1325-39. doi: 10.1016/j.addbeh.2004.06.020. Addict Behav. 2004. PMID: 15345268
-
Alcohol dependence, withdrawal, and relapse.Alcohol Res Health. 2008;31(4):348-61. Alcohol Res Health. 2008. PMID: 23584009 Free PMC article. Review.
Cited by
-
Alcohol-induced brain deficit in alcohol dependence.Front Neurol. 2022 Oct 25;13:1036164. doi: 10.3389/fneur.2022.1036164. eCollection 2022. Front Neurol. 2022. PMID: 36388224 Free PMC article.
-
The monoamine stabilizer (-)-OSU6162 counteracts downregulated dopamine output in the nucleus accumbens of long-term drinking Wistar rats.Addict Biol. 2016 Mar;21(2):438-49. doi: 10.1111/adb.12304. Epub 2015 Oct 14. Addict Biol. 2016. PMID: 26464265 Free PMC article.
-
Interaction between corticotropin-releasing factor, orexin, and dynorphin in the infralimbic cortex may mediate exacerbated alcohol-seeking behavior.Neurobiol Stress. 2024 Nov 19;33:100695. doi: 10.1016/j.ynstr.2024.100695. eCollection 2024 Nov. Neurobiol Stress. 2024. PMID: 39640001 Free PMC article.
-
Small molecule modulators of σ2R/Tmem97 reduce alcohol withdrawal-induced behaviors.Neuropsychopharmacology. 2018 Aug;43(9):1867-1875. doi: 10.1038/s41386-018-0067-z. Epub 2018 Apr 20. Neuropsychopharmacology. 2018. PMID: 29728649 Free PMC article.
-
Behavioral and Brain Activity Indices of Cognitive Control Deficits in Binge Drinkers.Brain Sci. 2018 Jan 4;8(1):9. doi: 10.3390/brainsci8010009. Brain Sci. 2018. PMID: 29300304 Free PMC article.
References
-
- Addolorato G, Leggio L, Agabio R, et al. (2006) Baclofen: a new drug for the treatment of alcohol dependence. Int J Clin Pract 60:1003–1008. - PubMed
-
- Anton RF, Kranzler H, Breder C, et al. (2008a) A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. J Clin Psychopharmacol 28:5–12. - PubMed
-
- Anton RF, Oroszi G, O’Malley S, et al. (2008b) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65:135–144. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical